Gabriel Wilmoth

Gabriel Wilmoth has a diverse work experience spanning multiple industries. Gabriel is currently serving as the Chief Operating Officer at Ascribe Bioscience since March 2021. Prior to this, they worked as a Board Member at Regrow Ag from August 2020 to May 2022, and as the Interim Chief Operating Officer at SomaDetect from September 2020 to March 2021.

Before their recent roles, Gabriel held the position of Chief Operating Officer at Growers, an ag software and data analytics company, from December 2017 to March 2020. During their tenure at Growers, the company was acquired by ICL in February 2020.

Gabriel also has experience in investment and board roles. Gabriel worked as an Investment Director at Syngenta Ventures from November 2016 to December 2017. Prior to this, they held roles such as Investment Manager and Investment Analyst at Syngenta Ventures from March 2015 to October 2016 and from July 2013 to March 2015, respectively. In these roles, they focused on early-stage venture capital investing in life science and agriculture-related technologies.

Additionally, Gabriel served as a Board Member at Premier Crop Systems from February 2017 to November 2017.

Prior to their ventures in the agriculture and investment sectors, Gabriel worked as a Consultant at Wilson Perumal & Company from January 2011 to June 2013. Gabriel also gained experience in operations management and continuous improvement as a Focus Factory Manager at Danaher from August 2008 to April 2010.

Gabriel's earlier career includes an Investment Banking Summer Associate role at Cowen and Company in 2007, and various roles at the University of Kentucky. At the University of Kentucky, they served as the Associate Director at the Von Allmen Center for Entrepreneurship from July 2003 to July 2006, and as the Program Coordinator for the Natural Products Alliance from December 2002 to July 2006.

Overall, Gabriel Wilmoth's work experience showcases their expertise in operations, investment, and entrepreneurship across the agricultural, biotech, and finance sectors.

Gabriel Wilmoth attended Harvard Business School from 2006 to 2008, where they obtained their MBA degree. Prior to this, they pursued their education at Virginia Tech, earning a Master's degree in Biochemistry, and a Bachelor's degree, also in Biochemistry. The exact years for their studies at Virginia Tech are unavailable.